Zhuoxin Sun

Also affiliated with Second Hospital of Hebei Medical University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults”.

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

Nature Medicine(2021)10.1038/s41591-021-01541-0

N/A

3.9DataRank · unranked

137 citations

Valsamo Anagnostou, Zhuoxin Sun, Suzanne E. Dahlberg, Hedy L. Kindler, Noushin Niknafs +22 more

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

Leukemia Research(2022)10.1016/j.leukres.2022.106971

N/A

0.613DataRank · unranked

9 citations

Zhuoxin Sun, Timour Baslan, Yanming Zhang, Mithat Gönen, Omar Abdel-Wahab +13 more

Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: An ECOG‐ACRIN analysis

Cancer(2023)10.1002/cncr.34807

N/A

0.400DataRank · unranked

8 citations

Zhuoxin Sun, Catherine Lai, Hugo F. Fernández, Larry D. Cripe, Rhett P. Ketterling +11 more

Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2021.100274

N/A

0DataRank · unranked

8 citations

Yating Wang, Zhuoxin Sun, Heather A. Wakelee, Suresh S. Ramalingam, Joan Schiller +1 more

Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999

Blood Cancer Journal(2022)10.1038/s41408-022-00736-z

N/A

0DataRank · unranked

1 citations

Kenneth Seier, Yaseswini Neelamraju, Duane C. Hassane, Timour Baslan, Daniel T. Gildea +21 more

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

The Breast(2020)10.1016/j.breast.2020.05.012

N/A

0DataRank · unranked

18 citations

Samuel M. Niman, Olivia Pagani, Ann H. Partridge, Hatem A. Azim, Fedro A. Peccatori +6 more

Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer

The Oncologist(2024)10.1093/oncolo/oyad335

N/A

0DataRank · unranked

2 citations

Yating Wang, Suresh S. Ramalingam, Sheena Bhalla, Zhuoxin Sun, Hossein Borghaei +3 more

ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps9077

N/A

0DataRank · unranked

31 citations

Sumithra J. Mandrekar, Geoffrey R. Oxnard, David Kozono, Shauna L. Hillman, Suzanne E. Dahlberg +13 more

Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia

British Journal of Haematology(2021)10.1111/bjh.17523

N/A

0DataRank · unranked

20 citations

Zhuoxin Sun, Larry D. Cripe, Jacob M. Rowe, Hugo F. Fernández, Selina M. Luger +5 more

A Review of Immunotherapy for Stage III and Metastatic Non-Small Cell Lung Cancer and the Rationale for the ECOG-ACRIN EA5181 Study

The Oncologist(2021)10.1002/onco.13725

N/A

0DataRank · unranked

5 citations

Zhuoxin Sun, Bonnie Ky, Jenica Upshaw, Sharyn I. Katz, Thomas J. FitzGerald +10 more